Skip to the page

Data / Drug companies / Clonidine hydrochloride

Clonidine hydrochloride: 45 companies and 145 products in the FDA NDC directory

Clonidine hydrochloride is listed in the FDA National Drug Code Directory by 45 companies, with 145 products in commercial distribution. 142 of the products (97.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; injection, solution, and the newest product started marketing on September 22, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
45
Products
145
Generic (ANDA) products
142 (97.9%)
Application numbers
20
Routes
Oral, Intravenous, Epidural
Brand names
Duraclon, Onyda XR, Qlonilik
openFDA record search
api.fda.gov

Companies that list clonidine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack11tabletGeneric drugs (ANDA)December 24, 2020
Remedyrepack Inc.9tabletGeneric drugs (ANDA)July 1, 2025
A-S Medication Solutions8tabletGeneric drugs (ANDA)June 2, 2021
Bryant Ranch Prepack7tabletGeneric drugs (ANDA)July 1, 2020
Bryant Ranch Prepack7tablet; tablet, extended releaseGeneric drugs (ANDA)June 2, 2021
NuCare Pharmaceuticals,Inc.7tabletGeneric drugs (ANDA)December 24, 2020
Northwind Health Company, LLC6tabletGeneric drugs (ANDA)December 6, 2022
Actavis Pharma, Inc.4tablet; tablet, extended releaseGeneric drugs (ANDA)June 17, 2015
Alembic Pharmaceuticals Inc.4tabletGeneric drugs (ANDA)September 22, 2026
Alembic Pharmaceuticals Limited4tabletGeneric drugs (ANDA)September 22, 2026
Asclemed USA, Inc.4tabletGeneric drugs (ANDA)June 1, 2017
BluePoint Laboratories4tablet; tablet, extended releaseGeneric drugs (ANDA)August 24, 2023
Preferred Pharmaceuticals Inc.4tabletGeneric drugs (ANDA)July 26, 2023
Proficient Rx LP4tabletGeneric drugs (ANDA)December 24, 2020
Solco Healthcare US, LLC4tablet; tablet, extended releaseGeneric drugs (ANDA)January 5, 2023
TruPharma, LLC4tabletGeneric drugs (ANDA)April 13, 2026
American Health Packaging3tablet; tablet, extended releaseGeneric drugs (ANDA)July 30, 2020
Asclemed USA Inc.3tabletGeneric drugs (ANDA)December 24, 2020
Aurobindo Pharma Limited3tabletGeneric drugs (ANDA)June 2, 2021
AvPAK3tabletGeneric drugs (ANDA)May 30, 2023
Cardinal Health 107, LLC3tabletGeneric drugs (ANDA)October 9, 2025
Coupler LLC3tabletGeneric drugs (ANDA)August 7, 2026
Method Pharmaceuticals, LLC3tabletGeneric drugs (ANDA)July 1, 2020
NCS HealthCare of Ky, LLC DBA Vangard Labs3tabletGeneric drugs (ANDA)January 3, 1995
Unichem Pharmaceuticals (USA), Inc.3tabletGeneric drugs (ANDA)December 24, 2020
Hikma Pharmaceuticals USA Inc.2injection, solutionGeneric drugs (ANDA)January 1, 2011
Major Pharmaceuticals2tabletGeneric drugs (ANDA)November 21, 2025
PD-Rx Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)September 21, 2009
Redpharm Drug2tabletGeneric drugs (ANDA)December 24, 2020
St. Mary's Medical Park Pharmacy2tabletGeneric drugs (ANDA)April 15, 2025
Unit Dose Solutions, Inc.2tabletGeneric drugs (ANDA)June 17, 2026
Verityrx, LLC2tabletGeneric drugs (ANDA)December 24, 2020
Ajanta Pharma USA Inc.1tablet, extended releaseGeneric drugs (ANDA)November 21, 2017
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)January 3, 1995
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)June 1, 2017
CMP Pharma, Inc.1solutionNew drug applications (NDA)August 28, 2026
Direct RX1tabletGeneric drugs (ANDA)April 4, 2019
Lupin Pharmaceuticals, Inc.1tablet, extended releaseGeneric drugs (ANDA)February 7, 2018
Mylan Institutional LLC1injection, solutionNew drug applications (NDA)January 26, 1997
NextWave Pharmaceuticals, Inc1suspension, extended releaseNew drug applications (NDA)August 13, 2024
NuCare Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)September 21, 2009
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)May 3, 2016
Proficient Rx LP1tabletGeneric drugs (ANDA)September 4, 1987
Somerset Therapeutics, LLC1tablet, extended releaseGeneric drugs (ANDA)March 4, 2025
Xiamen LP Pharmaceutical Co., Ltd.1tablet, extended releaseGeneric drugs (ANDA)December 1, 2017

Dosage forms

Dosage formProductsShare
Tablet13190.3%
Tablet, extended release96.2%
Injection, solution32.1%
Suspension, extended release10.7%
Solution10.7%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)14297.9%
New drug applications (NDA)32.1%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.